Joshua Waitzman, MD PhD(@Jwaitz) 's Twitter Profileg
Joshua Waitzman, MD PhD

@Jwaitz

Kidney doc, biochemist, and dad, taking life one kinesin-sized step at a time. He/him. @BIDMChealth | @nufeinbergmed | loudmouth @bookburton and @freelyfiltered

ID:53529588

linkhttps://connects.catalyst.harvard.edu/Profiles/display/Person/184566 calendar_today03-07-2009 23:17:52

7,7K Tweets

3,0K Followers

3,5K Following

Joshua Waitzman, MD PhD(@Jwaitz) 's Twitter Profile Photo

Classic Dr. Zuromskis BIDMC IM Residency mastery in this diagnostic dilemma.

I asked him how he knew what the patient had--'you've seen one person with chikingunya virus, you've seen 'em all'

Sure Dr. Z.

nytimes.com/2023/11/20/mag…

account_circle
Rhodes Hambrick, MD(@RhodesHambrick) 's Twitter Profile Photo

Joshua Waitzman, MD PhD Joel M. Topf, MD FACP well you see it all starts when a hairpin loop of Henle and vasa recta capillary bed love each other very much and have STRONG opinions about locoregional solute or water permeability

account_circle
Joshua Waitzman, MD PhD(@Jwaitz) 's Twitter Profile Photo

And after 2 whirlwind days I’m shipping up to Boston!

Thanks NU Internal Medicine Northwestern Kidney for the warm welcome home.

I got to talk HTN with residents, career with PSTP residents, APOL1 with nephrology, and ion channels with pharmacology. It doesn’t get better than that!

And after 2 whirlwind days I’m shipping up to Boston! Thanks @NU_IntMed @NU_Nephrology for the warm welcome home. I got to talk HTN with residents, career with PSTP residents, APOL1 with nephrology, and ion channels with pharmacology. It doesn’t get better than that!
account_circle
Roger Rodby(@NephRodby) 's Twitter Profile Photo

Joel M. Topf, MD FACP 1) Thanks Joel. I cannot imagine my professional trajectory had it not been for landing at Rush Nephrology in 1985. SGLT2i is all the rage, but renoprotection all started with RAASi that he took from Dr. Brenner's lab to clinical practice. It changed EVERYTHING for pts with CKD

account_circle
Pradeep Natarajan(@pnatarajanmd) 's Twitter Profile Photo

SELECT “establishes overweight and obesity as a modifiable risk factor for cardiovascular disease” -AM Lincoff 🔥 nejm.org/doi/full/10.10… NEJM AHA Science

account_circle
Northwestern Kidney(@NU_Nephrology) 's Twitter Profile Photo

📢 We've got a fantastic guest speaker joining us on Tuesday, November 14th!

Dr. Joshua Waitzman, MD, PhD Joshua Waitzman, MD PhD, will be sharing insights about APOL1-associated kidney diseases in the Daniel Hale Williams Auditorium at noon.

Don't miss out—we'd love to see you there!

📢 We've got a fantastic guest speaker joining us on Tuesday, November 14th! Dr. Joshua Waitzman, MD, PhD @Jwaitz, will be sharing insights about APOL1-associated kidney diseases in the Daniel Hale Williams Auditorium at noon. Don't miss out—we'd love to see you there!
account_circle
Ben Humphreys(@HumphreysLab) 's Twitter Profile Photo

What a great early start with a group run on the Schuylkill with old friends and new! 🙏🙏 to Jennie Lin 👩🏻‍⚕️🧬 for organizing 🏃🏃‍♀️🏃🏻‍♂️

What a great early #Kidneywk start with a #850Challenge group run on the Schuylkill with old friends and new! 🙏🙏 to @jenniejlin for organizing 🏃🏃‍♀️🏃🏻‍♂️
account_circle
Joshua Waitzman, MD PhD(@Jwaitz) 's Twitter Profile Photo

At the glom disease mechanisms session in 204; Anna Greka is presenting a high throughput, multi-modality approach to studying the toxic effects of different circulating free fatty acids.

pubmed.ncbi.nlm.nih.gov/37075753/

account_circle
Joel M. Topf, MD FACP(@kidney_boy) 's Twitter Profile Photo

Don’t let the negative top line discourage you. The podcast is great and they executed a lot of innovative ideas to try to improve transplant. Listen to the podcast.

account_circle